Advertisement NeoStem raises $0.9 million in financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

NeoStem raises $0.9 million in financing

NeoStem has announced a private placement financing in a total amount of $0.9 million, which includes a strategic investment from the New England Cryogenic Center.

The financing consists of units priced at $1.20 per unit with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at $1.75 per share.

Robin Smith, CEO of NeoStem, said: “These funds will be instrumental in executing on our plan to educate potential clientele about our services, particularly in the Northeast which we believe will be a powerful market.”